Ruxolitinib (INCB018424) is a first-in-class, potent and selective JAK1/2 inhibitor with an IC50 of 3.3 nM/2.8 nM. It is 130-fold more potent and selective for JAK1 and JAK2 compared to JAK3. In Ba/F3 and HEL cells, INCB018424 potently and selectively inhibited JAK2V617F-mediated signaling and cell proliferation.INCB018424 significantly increased apoptosis in Ba/F3 cells in a dose-dependent manner. In Ba/F3 cells, INCB018424 (64 nM) caused a doubling of mitochondrial depolarized cells.
Nat Commun. 2023 Nov 27;14(1):7783.
Local H2 release remodels senescence microenvironment for improved repair of injured bone
INCB18424 purchased from AbMole
FASEB J. 2023 Feb;37(2):e22693.
ANGPTL4 inhibits granulosa cell proliferation in polycystic ovary syndrome by EGFR/JAK1/STAT3‐mediated induction of p21
INCB18424 purchased from AbMole
Front Immunol. 2022 May 23;13:866638.
A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease
INCB18424 purchased from AbMole
BMC Biol. 2021 May 20;19(1):108.
Very long intergenic non-coding (vlinc) RNAs directly regulate multiple genes in cis and trans
INCB18424 purchased from AbMole
Blood Adv. 2020 Jul 14;4(13):3000-3010.
Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro
INCB18424 purchased from AbMole
J Virol. 2020 Feb 14;94(5):e01791-19.
Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use
INCB18424 purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | Ba/F3-EpoR-JAK2V617F and HEL cell lines |
Preparation method | Cell proliferation assay. Cells were seeded at 2000/well of white bottom 96-well plates, treated with compounds from DMSO stocks (0.2% final DMSO concentration), and incubated for 48 hours at 37°C with 5% CO2. Viability was measured by cellular ATP determination using the Cell-Titer Glo (Promega) luciferase reagent or viable cell counting. Values were transformed to percent inhibition relative to vehicle control, and IC50 curves were fitted according to nonlinear regression analysis of the data using PRISM GraphPad. |
Concentrations | 0~10 µ M |
Incubation time | 48 h |
Animal Experiment | |
---|---|
Animal models | myeloproliferative neoplasm mouse model |
Formulation | 5% dimethyl acetamide, 0.5% methocellulose |
Dosages | 180mg/kg began within 24 hours of cell inoculation, twice daily |
Administration | oral gavage |
Molecular Weight | 306.37 |
Formula | C17H18N6 |
CAS Number | 941678-49-5 |
Solubility (25°C) | DMSO 60 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
Related JAK Products |
---|
A-005
A-005 is a potentially first-in-class, brain-penetrating TYK2 allosteric inhibitor for studies related to neuroinflammatory and neurodegenerative diseases. |
Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9)
Tyrosine Protein Kinase JAK 2 (Phospho-Tyr8, 9) is a peptide corresponding to amino acids 475 to 491 of mouse JAK2. |
JAK2/FLT3-IN-1 TFA
JAK2/FLT3-IN-1 (TFA) is a potent and orally active dual JAK2/FLT3 inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively. |
ZT55
ZT55 is an orally active and highly-selective JAK2 inhibitor with an IC50 value of 0.031 μM. |
ZM39923
ZM39923 is a JAK3 inhibitor, with a pIC50 of 7.1; ZM39923 also potently inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.